Skip to main content
MicroPort NeuroScientic Corporation logo

MicroPort NeuroScientic Corporation — Investor Relations & Filings

Ticker · 2172 HKEX Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2025-08-15 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2172

About MicroPort NeuroScientic Corporation

https://www.microportneurosci.com

MicroPort NeuroScientific Corporation is a medical technology company specializing in the research, development, manufacturing, and marketing of neuro-interventional medical devices. The company is dedicated to providing accessible, top-quality, and comprehensive solutions for stroke patients globally. Its product portfolio addresses complex neurovascular diseases, including intracranial aneurysms, cerebral atherosclerosis stenosis, and acute cerebral embolism. Key offerings include advanced devices such as the NUMEN coil embolization system. The corporation maintains a leading position in the neuro-interventional field, with its solutions utilized extensively across major healthcare systems.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Regulatory Filings Classification · 1% confidence The document is a notice from the company announcing the date of an upcoming Board meeting to consider and approve interim results and dividend. It is not the interim report itself, nor the publication of such; it is simply a regulatory announcement of the board meeting date. There is no specific category for “Board meeting notice,” so this falls under the general regulatory filings category (RNS).
2025-08-15 English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 31 July 2025
Share Issue/Capital Change Classification · 1% confidence The document is a routine monthly return filed with HKEX (Form FF301) detailing movements in authorised/registered share capital, issued shares, treasury shares, and share options exercised during the month. It is not an earnings release, AGM materials, or financial report but a regulatory announcement of share capital changes. This clearly aligns with "Share Issue/Capital Change" rather than a general regulatory fallback. Therefore, the correct classification is SHA.
2025-08-05 English
Final Dividend for the year ended 31 December 2024
Notice of Dividend Amount Classification · 1% confidence The document is an announcement by a Hong Kong listed issuer detailing the final dividend for the year ended 31 December 2024, including dividend amount per share, scrip option terms, record date, payment date, ex-dividend date, and related shareholder information. This fits the definition of a ‘Notice of Dividend Amount’ (Code: DIV).
2025-07-22 English
SCRIP SHARE ELECTION FORM
Notice of Dividend Amount Classification · 1% confidence The document is a Scrip Share Election Form relating to the final dividend for year ended 31 December 2024. It provides instructions and a form for shareholders to elect to receive shares instead of cash for their dividend entitlement. This is directly tied to the company’s dividend distribution process and requires shareholder action on a dividend payment. The most appropriate category for a shareholder-facing dividend notification and election form is “Notice of Dividend Amount” (DIV).
2025-07-22 Chinese
SCRIP DIVIDEND SCHEME IN RELATION TO THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
Notice of Dividend Amount Classification · 1% confidence The document is a shareholder circular from the Board detailing the Scrip Dividend Scheme in relation to the final dividend for the year ended 31 December 2024, including dividend amount, election procedures, record date and payment options. It is not the full annual or interim financial report, nor a proxy solicitation, nor a general regulatory filing. It is a notice to shareholders of the dividend amount and election details. Therefore, it fits the “Notice of Dividend Amount” category (Code: DIV).
2025-07-22 English
Monthly Return of Equity Issuers on Movements in Securities for the month ended 30 June 2025
Regulatory Filings Classification · 1% confidence The document is a Form FF301 Monthly Return under HKEX Listing Rules (Chapter 19B) detailing movements in authorised share capital, issued shares, treasury shares, share options, and repurchases. It is a required periodic regulatory return rather than a standalone management report, earnings release, investor presentation, or capital fundraising announcement. It does not represent an annual or interim financial report but a compliance filing under exchange rules. As it does not match more specific categories, it falls under the general Regulatory Filings category (RNS).
2025-07-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.